MHH Human Genetics improves the diagnosis of rare diseases in order to individualize therapies for critically ill newborns and children.

MHH researchers discover a previously unknown signaling pathway for the formation of new blood vessels to aid in the recovery of the infarct region.

MHH researchers have deciphered the signaling pathway that controls the movement of mitochondria within cells during heart development.

For a healthy control group, subjects without gaming disorder are sought.

Researchers from MHH and LUH are investigating how misdirected cell control triggers the closure of the cranial sutures.

MHH research team wants to find biomarkers for underlying diseases in interstitial nephritis and is being funded with half a million euros.

MHH researchers find novel regulatory RNA that controls inflammation and scarring of the heart muscle during repair processes.

Professor Meike Stiesch is the new Dean of Research at the MHH.

Research network FOR 5250 in cooperation with TU Dortmund University is being funded by the DFG for a further four years.

MHH doctoral student receives research grant to develop more sustainable methods for cultivating stem cells.